Role of big data for evaluation and supervision of medicines in the EU

February 15, 2019 – Recommendations for a path towards understanding the acceptability of evidence derived from ‘Big data’ in support of the evaluation and supervision of medicines by regulators were published today as part of a PDF iconsummary report of the Heads of Medicines Agencies (HMA) – EMA Joint Big Data task force . The recommendations and associated actions set out what needs to be addressed, but the mechanisms by which this may be … (leggi tutto)